An Official Website of the United States Government
Company Information:
Name:
APPLIED GENETIC TECHNOLOGIES CORPORATION
Address:
APPLIED GENETIC TECHNOLOGIES CRP
12085 RESEARCH DR, STE 110
ALACHUA, FL 32615-0683
12085 RESEARCH DR, STE 110
ALACHUA, FL 32615-0683
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(386) 462-2204
Award Totals:
Award List:
TREATMENT OF ANEMIA USING AAV VECTORS
Award Year / Program / Phase:
2001 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Mark C. Walker
Award Amount:
$256,725.00
Abstract:
DESCRIPTION (applicant's abstract): The innovative use of AAV vector technology
is proposed to develop milestones essential for the safe treatment of anemia
secondary to chronic renal failure in cats. An A.AV-FeEPO vector has been
constructed. The initial, in vitro, study… More
Molecular Breeding of Gene Therapy Vectors
Award Year / Program / Phase:
2003 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Kyukye Hwang
Award Amount:
$131,711.00
Abstract:
DESCRIPTION (provided by applicant): We propose to develop Gene Therapy vectors that are targeted to particular cell membrane receptors, cell types and/or tissues. Development of these precise delivery systems will help overcome potential adverse reactions and high dosing requirements imposed by the… More
rAAV5-hCNGB3 Gene Therapy for Achromatopsia: Efficacy in a Dog Model
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Jeffrey D. Chulay
Award Amount:
$143,082.00
Abstract:
DESCRIPTION (provided by applicant): Complete achromatopsia is an inherited retinal disorder characterized by severely reduced visual acuity, nystagmus, severe photophobia, a small central scotoma, eccentric fixation, and complete loss of color discrimina
tion. In 50% of patients with achromatopsia… More